Antifungal Activity and Mechanism of Xenocoumacin 1, a Natural Product from Xenorhabdus nematophila against Sclerotinia sclerotiorum

Shujing Zhang,Yunfei Han,Lanying Wang,Jinhua Han,Zhiqiang Yan,Yong Wang,Yonghong Wang
DOI: https://doi.org/10.3390/jof10030175
2024-02-26
Journal of Fungi
Abstract:Sclerotinia sclerotiorum (Lib.) de Bary, a polyphagous necrotrophic fungal pathogen, has brought about significant losses in agriculture and floriculture. Until now, the most common method for controlling S. sclerotiorum has been the application of fungicides. Xenocoumacin 1 (Xcn1) is a potential biopesticide having versatile antimicrobial activities, generated by Xenorhabdus nematophila. This study was intended to isolate Xcn1 from X. nematophila YL001 and clarify its efficacies for S. sclerotiorum control. Xcn1 demonstrated a wider antifungal spectrum against 10 plant-pathogenic fungi. It also exhibited a strong inhibitory effect on the mycelial growth of S. sclerotiorum with an EC50 value of 3.00 μg/mL. Pot experiments indicated that Xcn1 effectively inhibited disease extension on oilseed rape and broad bean plants caused by S. sclerotiorum. Morphological and ultrastructural observations revealed that the hyphae of S. sclerotiorum became twisted, shriveled, and deformed at the growing points after treatment with Xcn1 at 3.00 μg/mL and that the subcellular fractions also became abnormal concurrently, especially the mitochondrial structure. Moreover, Xcn1 also increased cell membrane permeability and decreased the content of exopolysaccharide as well as suppressing the activities of polygalacturonase and cellulase of S. sclerotiorum, but exerted no effects on oxalic acid production. This study demonstrated that Xcn1 has great potential to be developed as a new biopesticide for the control of S. sclerotiorum.
microbiology,mycology
What problem does this paper attempt to address?
The paper mainly addresses the following issues: ### Research Background and Objectives - **Research Background**: _Sclerotinia sclerotiorum_ is a necrotrophic fungal pathogen with a wide host range, causing significant losses to over 400 plant species worldwide, including canola, lentils, and sunflowers. The primary method of controlling this pathogen is the use of chemical fungicides, but this approach faces challenges such as drug resistance and threats to human health and environmental safety. - **Research Objectives**: To isolate Xenocoumacin 1 (Xcn1) from _Xenorhabdus nematophila_ and evaluate its potential as a biopesticide against _Sclerotinia sclerotiorum_ and its mechanism of action. ### Main Research Findings 1. **Antifungal Activity of Xcn1**: Xcn1 exhibited a broad antifungal spectrum and showed strong inhibitory effects against _Sclerotinia sclerotiorum_ (EC50 value of 3.00 µg/mL). 2. **In Vivo Disease Resistance Tests**: In vivo disease resistance tests were conducted on two host plants (broadleaf mustard and canola), and the results showed that Xcn1 effectively inhibited disease development caused by _Sclerotinia sclerotiorum_. 3. **Morphological and Ultrastructural Observations**: Scanning electron microscopy (SEM) and transmission electron microscopy (TEM) observations indicated that the hyphae of _Sclerotinia sclerotiorum_ treated with Xcn1 exhibited characteristics such as twisting, shrinkage, and deformation. There was an increase in cell membrane permeability, a reduction in extracellular polysaccharide secretion, and inhibition of polygalacturonase (PG) and cellulase (Cx) activities. 4. **Effect on Oxalic Acid Synthesis**: Although Xcn1 significantly inhibited the growth of _Sclerotinia sclerotiorum_, it did not affect the biosynthesis of oxalic acid. ### Conclusion - Xcn1 has the potential to be developed as a novel biopesticide for controlling _Sclerotinia sclerotiorum_, particularly by inhibiting hyphal growth and infection processes. - It exerts its antifungal activity by interfering with various physiological and biochemical processes, such as increasing cell membrane permeability, reducing extracellular polysaccharide secretion, and inhibiting related enzyme activities. - Xcn1 may act by inhibiting protein translation, although further research is needed to confirm this. - Combining Xcn1 with oxalic acid synthesis inhibitors could be an effective strategy for controlling _Sclerotinia sclerotiorum_.